Dimensional Fund Advisors
CMPX icon

Dimensional Fund Advisors’s Compass Therapeutics CMPX Stock Holding History

Dimensional Fund Advisors’s Portfolio CMPX Stock Details CMPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.32M Buy
439,784
+98,188
+29% +$567K ﹤0.01% 2669
2025
Q4 		$1.83M Buy
341,596
+166,040
+95% +$767K ﹤0.01% 2751
2025
Q3 		$619K Buy
175,556
+3,329
+2% +$10.5K ﹤0.01% 2957
2025
Q2 		$447K Buy
172,227
+33,425
+24% +$68.9K ﹤0.01% 3013
2025
Q1 		$264K Buy
138,802
+127,685
+1,149% +$340K ﹤0.01% 3095
2024
Q4 		$16.1K Hold
11,117
– – ﹤0.01% 3330
2024
Q3 		$20.5K Hold
11,117
– – ﹤0.01% 3334
2024
Q2 		$11.1K Hold
11,117
– – ﹤0.01% 3365
2024
Q1 		$22K Hold
11,117
– – ﹤0.01% 3364
2023
Q4 		$17.3K Sell
11,117
-44
-0.4% -$76 ﹤0.01% 3394
2023
Q3 		$22K Sell
11,161
-19,289
-63% -$47.7K ﹤0.01% 3438
2023
Q2 		$96.8K Buy
+30,450
New +$95.6K ﹤0.01% 3327

Other funds holding CMPX

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Dimensional Fund Advisors's CMPX Position: Q1 2026 in Review

Dimensional Fund Advisors increased its Compass Therapeutics (CMPX) stake by 29% in Q1 2026, buying an estimated $567K and bringing the position to 439,784 shares worth $2.32M. The position accounts for ﹤0.01% of the portfolio, ranked #2669.

Dimensional Fund Advisors first reported a position in CMPX in Q2 2023 and has held it in 12 quarters since. 201 funds tracked by Wall St. Rank hold CMPX as of Q1 2026.

  • Dimensional Fund Advisors held 439,784 shares of Compass Therapeutics worth $2.32M as of Q1 2026.
  • Dimensional Fund Advisors bought 98,188 Compass Therapeutics shares in Q1 2026, an estimated $567K.
  • Compass Therapeutics made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q1 2026, its #2669 holding.
  • Dimensional Fund Advisors first reported a position in Compass Therapeutics in Q2 2023 and has held it in 12 quarters since.
  • 201 funds tracked by Wall St. Rank held Compass Therapeutics as of Q1 2026.

Based on Dimensional Fund Advisors's 13F filing for Q1 2026, filed 7 May 2026.